journal article·2023-05-17Open access

In Vitro Study of the Anti-inflammatory and Antifibrotic Activity of Tannic Acid-Coated Curcumin-Loaded Nanoparticles in Human Tenocytes

Giuseppina Molinaro, Flavia Fontana, Rubén Pareja Tello, Shiqi Wang, Sandra López Cérda, Giulia Torrieri, Alexandra Correia, Eero Waris, Jouni T. Hirvonen, Goncalo Barreto, Hélder A. Santos

ACS Applied Materials & Interfaces· Volume 15· Issue 19

Abstract

Tendinitis is a tendon disorder related to inflammation and pain, due to an injury or overuse of the tissue, which is hypocellular and hypovascular, leading to limited repair which occurs in a disorganized deposition of extracellular matrix that leads to scar formation and fibrosis, ultimately resulting in impaired tendon integrity. Current conventional treatments are limited and often ineffective, highlighting the need for new therapeutic strategies. In this work, acetalated-dextran nanoparticles (AcDEX NPs) loaded with curcumin and coated with tannic acid (TA) are developed to exploit the anti-inflammatory and anti-fibrotic properties of the two compounds. For this purpose, a microfluidic technique was used in order to obtain particles with a precise size distribution, aiming to decrease the batch-to-batch variability for possible future clinical translation. Coating with TA increased not only the stability of the nanosystem in different media but also enhanced the interaction and the cell-uptake in primary human tenocytes and KG-1 macrophages. The nanosystem exhibited good biocompatibility toward these cell types and a good release profile in an inflammatory environment. The efficacy was demonstrated by real-time quantitative polymerase chain reaction, in which the curcumin loaded in the particles showed good anti-inflammatory properties by decreasing the expression of NF-κb and TA-coated NPs showing anti-fibrotic effect, decreasing the gene expression of TGF-β. Overall, due to the loading of curcumin and TA in the AcDEX NPs, and their synergistic activity, this nanosystem has promising properties for future application in tendinitis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Tendon Structure and Treatment · Bee Products Chemical Analysis · Advancements in Transdermal Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Fabianinkatu 33, 00014 Helsinki, Finland

Department of Hand Surgery, University of Helsinki and Helsinki University Hospital, 00029 HUS Helsinki, Finland

Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, PL 4 (Yliopistonkatu 3), 00014 Helsinki, Finland

Medical Ultrasonics Laboratory (MEDUSA), Department of Neuroscience and Biomedical Engineering, Aalto University, 02150 Espoo, Finland

Orton Orthopedic Hospital, Tenholantie 10, 00280 Helsinki, Finland

Department of Biomedical Engineering, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, 9713 AV Groningen, The Netherlands

W. J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, 9713 AV Groningen, The Netherlands

Funding

Luonnontieteiden ja Tekniikan Tutkimuksen Toimikunta · Terveyden Tutkimuksen Toimikunta · Universitair Medisch Centrum Groningen · H2020 Marie Sklodowska-Curie Actions

References (52)

Show source-provided references
1. Kaux J.-F. · J. Sports Sci. Med. · 2011 · 10 · 238
2. 10.1097/00000658-195104000-0001910.1097/00000658-195104000-00019 ↗
3. 10.1016/j.carbpol.2020.11628410.1016/j.carbpol.2020.116284 ↗
4. 10.1007/bf0038757710.1007/bf00387577 ↗
5. 10.1002/art.2242610.1002/art.22426 ↗
6. 10.1002/jor.2466710.1002/jor.24667 ↗
7. 10.1074/jbc.m112.35542010.1074/jbc.m112.355420 ↗
8. 10.3390/nu1410203010.3390/nu14102030 ↗
9. 10.1038/s41572-020-00234-110.1038/s41572-020-00234-1 ↗
10. 10.1186/s13075-016-1165-010.1186/s13075-016-1165-0 ↗
11. 10.1002/wnan.163010.1002/wnan.1630 ↗
12. 10.1111/1440-1681.1257710.1111/1440-1681.12577 ↗
13. 10.1002/bit.2130110.1002/bit.21301 ↗
14. 10.1080/00914037.2020.179843610.1080/00914037.2020.1798436 ↗
15. 10.1016/j.progpolymsci.2016.05.00510.1016/j.progpolymsci.2016.05.005 ↗
16. Ventola C. L. · P T · 2012 · 37 · 512
17. 10.1021/acs.chemrev.6b0053210.1021/acs.chemrev.6b00532 ↗
18. 10.1039/d1cc00811k10.1039/d1cc00811k ↗
19. 10.1016/j.jconrel.2022.09.06710.1016/j.jconrel.2022.09.067 ↗
20. 10.1021/am300888810.1021/am3008888 ↗
21. 10.1016/j.ijpharm.2016.08.03110.1016/j.ijpharm.2016.08.031 ↗
22. 10.1016/j.jddst.2022.10359810.1016/j.jddst.2022.103598 ↗
23. 10.1016/j.jconrel.2020.09.04410.1016/j.jconrel.2020.09.044 ↗
24. 10.1074/jbc.m111.25618010.1074/jbc.m111.256180 ↗
25. 10.1016/j.xphs.2022.10.02210.1016/j.xphs.2022.10.022 ↗
26. 10.1016/j.carbpol.2021.11824610.1016/j.carbpol.2021.118246 ↗
27. 10.1186/s12931-019-1141-810.1186/s12931-019-1141-8 ↗
28. 10.1039/c7lc00242d10.1039/c7lc00242d ↗
29. 10.1021/acsami.8b2082110.1021/acsami.8b20821 ↗
30. 10.1002/adma.20140540810.1002/adma.201405408 ↗
31. 10.1021/la101246a10.1021/la101246a ↗
32. 10.1002/adfm.20210903210.1002/adfm.202109032 ↗
33. 10.1002/adma.20160323910.1002/adma.201603239 ↗
34. 10.1038/nprot.2007.10210.1038/nprot.2007.102 ↗
35. 10.1021/i560096a01310.1021/i560096a013 ↗
36. 10.1039/c5ra19405a10.1039/c5ra19405a ↗
37. 10.1002/adfm.20180135510.1002/adfm.201801355 ↗
38. 10.1126/science.123726510.1126/science.1237265 ↗
39. 10.1016/j.lfs.2016.04.00310.1016/j.lfs.2016.04.003 ↗
40. 10.1021/acsomega.2c0272710.1021/acsomega.2c02727 ↗
41. 10.1038/s41598-022-15020-010.1038/s41598-022-15020-0 ↗
42. 10.1080/10717544.2018.150283910.1080/10717544.2018.1502839 ↗
43. 10.1038/s41565-021-00858-810.1038/s41565-021-00858-8 ↗
44. 10.1038/mt.2009.28110.1038/mt.2009.281 ↗
45. 10.1016/j.virol.2010.02.01510.1016/j.virol.2010.02.015 ↗
46. 10.1016/0142-9612(95)93257-e10.1016/0142-9612(95)93257-e ↗
47. 10.1016/0014-4827(80)90279-710.1016/0014-4827(80)90279-7 ↗
48. 10.1097/cad.0b013e32834a099c10.1097/cad.0b013e32834a099c ↗
49. 10.1002/bip.2240510.1002/bip.22405 ↗
50. 10.11138/mltj/2013.3.1.05110.11138/mltj/2013.3.1.051 ↗
51. 10.1016/j.numecd.2009.03.00110.1016/j.numecd.2009.03.001 ↗
52. 10.1111/os.1241210.1111/os.12412 ↗